March 22, 2023

Local 12 highlighted the University of Cincinnati's Bingfang Yan, who recently received a a $2.5 million National Institutes of Health grant to study how COVID-19 therapeutics can work together to create more effective and safe treatments for patients.

April 10, 2023

The University of Cincinnati's Kelly Dobos walked the Wall Street Journal through ingredients in a commercially available foundation from a "clean beauty" brand.

April 7, 2023

Drug Discovery News highlighted research coauthored by the University of Cincinnati's Timothy Phoenix that found a gene called FOXR2 is abnormally expressed in more than 70% of cancer types sampled and could be a potential target for new treatments.